InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mirum Pharmaceuticals, Inc.

MIRM Clue Score61
United States Fiscal year ends December CIK 0001759425 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
Eric Bjerkholt
14 Sep 2026
Chief Financial Officer
Sell
9,943
$98.37
$978.09K
Saira Ramasastry
1 Jun 2026
Director
Sell
3,977
$100.00
$397.70K
Christopher Peetz
16 Mar 2026
Chief Executive Officer
Sell
40,985
$91.98
$3.77M
Jolanda Howe
16 Mar 2026
SVP, Global Controller
Sell
4,732
$91.98
$435.24K
Peter Radovich
16 Mar 2026
President and COO
Sell
16,515
$91.98
$1.52M
Joanne Quan
16 Mar 2026
Chief Medical Officer
Sell
7,287
$91.98
$670.24K
Eric Bjerkholt
16 Mar 2026
Chief Financial Officer
Sell
7,287
$91.98
$670.24K
Jolanda Howe
2 Feb 2026
SVP, Global Controller
Sell
968
$103.30
$100.00K
Christopher Peetz
2 Feb 2026
Chief Executive Officer
Sell
9,108
$103.30
$940.89K
Peter Radovich
2 Feb 2026
President and COO
Sell
2,631
$103.30
$271.79K
Christopher Peetz
26 Jan 2026
Chief Executive Officer
Sell
6,831
$96.19
$657.09K
Jolanda Howe
26 Jan 2026
SVP, Global Controller
Sell
842
$96.19
$80.99K
Peter Radovich
26 Jan 2026
President and COO
Sell
3,143
$96.19
$302.33K
Eric Bjerkholt
26 Jan 2026
Chief Financial Officer
Sell
1,053
$96.19
$101.29K
Christopher Peetz
22 Jan 2026
Chief Executive Officer
Sell
7,098
$93.33
$662.42K
Peter Radovich
22 Jan 2026
President and COO
Sell
2,382
$93.33
$222.30K
Eric Bjerkholt
22 Jan 2026
Chief Financial Officer
Sell
1,421
$93.33
$132.62K
Joanne Quan
22 Jan 2026
Chief Medical Officer
Sell
1,822
$93.33
$170.04K
Jolanda Howe
22 Jan 2026
SVP, Global Controller
Sell
926
$93.33
$86.42K
Joanne Quan
20 Jan 2026
Chief Medical Officer
Sell
6,911
$90.27
$623.85K
Eric Bjerkholt
12 Sep 2025
Chief Financial Officer
Sell
9,578
$76.01
$728.02K
Eric Bjerkholt
11 Aug 2025
Chief Financial Officer
Sell
8,000
—
no price
William Fairey
11 Jun 2025
Director
Sell
3,203
$48.42
$155.09K
Saira Ramasastry
2 Jun 2025
Director
Sell
5,703
$46.20
$263.49K
Christopher Peetz
17 Mar 2025
Chief Executive Officer
Sell
27,279
$44.21
$1.21M
Peter Radovich
17 Mar 2025
President and COO
Sell
7,879
$44.21
$348.36K
Peter Radovich
4 Mar 2025
President and COO
Sell
1,169
$45.74
$53.47K
Peter Radovich
4 Mar 2025
President and COO
Sell
13,681
$45.57
$623.46K
Jolanda Howe
3 Feb 2025
SVP, Global Controller
Sell
1,064
$48.22
$51.31K
Christopher Peetz
3 Feb 2025
Chief Executive Officer
Sell
9,102
$48.22
$438.92K
Peter Radovich
3 Feb 2025
President and COO
Sell
2,627
$48.22
$126.68K
Christopher Peetz
24 Jan 2025
Chief Executive Officer
Sell
6,837
$47.92
$327.66K
Jolanda Howe
24 Jan 2025
SVP, Global Controller
Sell
902
$47.92
$43.23K
Peter Radovich
24 Jan 2025
President and COO
Sell
3,177
$47.92
$152.26K
Joanne Quan
17 Jan 2025
Chief Medical Officer
Sell
6,969
$45.86
$319.60K
Jolanda Howe
7 Jan 2025
SVP, Global Controller
Sell
750
$42.82
$32.11K
Christopher Peetz
7 Jan 2025
Chief Executive Officer
Sell
7,489
$42.82
$320.64K
Peter Radovich
7 Jan 2025
President and COO
Sell
1,998
$42.82
$85.54K
Jolanda Howe
2 Jul 2024
SVP, Global Controller
Sell
375
$34.00
$12.75K
Peter Radovich
25 Mar 2024
President and COO
Sell
4,303
$25.80
$111.02K
Jolanda Howe
2 Feb 2024
SVP, Global Controller
Sell
735
$26.19
$19.25K
Christopher Peetz
2 Feb 2024
Chief Executive Officer
Sell
6,013
$26.19
$157.49K
Peter Radovich
2 Feb 2024
President and COO
Sell
1,790
$26.19
$46.88K
Lara Longpre
2 Feb 2024
Chief Development Officer
Sell
847
$26.19
$22.18K
Pamela Vig
2 Feb 2024
Chief Scientific Officer
Sell
1,214
$26.19
$31.80K
Jolanda Howe
8 Jan 2024
SVP, Global Controller
Sell
528
$28.04
$14.80K
Christopher Peetz
8 Jan 2024
President and CEO
Sell
5,209
$28.03
$146.03K
Pamela Vig
8 Jan 2024
Head of Research & Development
Sell
1,408
$28.03
$39.47K
Lara Longpre
8 Jan 2024
Chief Development Officer
Sell
1,019
$28.04
$28.57K
Peter Radovich
8 Jan 2024
Chief Operating Officer
Sell
1,408
$28.03
$39.47K
Jolanda Howe
25 Aug 2023
SVP, Global Controller
Sell
3,459
$26.23
$90.74K
Christopher Peetz
3 Jul 2023
President and CEO
Sell
5,498
$25.65
$141.01K
Jolanda Howe
3 Jul 2023
SVP, Global Controller
Sell
915
$25.65
$23.47K
Pamela Vig
3 Jul 2023
Head of Research & Development
Sell
1,425
$25.65
$36.55K
Lara Longpre
3 Jul 2023
Chief Development Officer
Sell
1,004
$25.65
$25.75K
Peter Radovich
3 Jul 2023
Chief Operating Officer
Sell
1,425
$25.65
$36.55K
Christopher Peetz
9 Jan 2023
Chief Executive Officer
Sell
5,159
$20.62
$106.39K
Lara Longpre
9 Jan 2023
Chief Development Officer
Sell
1,003
$20.62
$20.68K
Pamela Vig
9 Jan 2023
Chief Scientific Officer
Sell
1,379
$20.62
$28.44K
Peter Radovich
9 Jan 2023
President and COO
Sell
1,379
$20.62
$28.44K
Niall O'Donnell
15 Nov 2022
Director
Sell indirect
93,770
$19.69
$1.85M
Niall O'Donnell
14 Nov 2022
Director
Sell indirect
32,109
$19.60
$629.42K
Niall O'Donnell
11 Nov 2022
Director
Sell indirect
174,121
$19.99
$3.48M
James E Flynn
6 Jun 2022
10% owner
Sell indirect
6,243
$24.47
$152.77K
James E Flynn
6 Jun 2022
10% owner
Sell indirect
6,909
$24.47
$169.06K
James E Flynn
6 Jun 2022
10% owner
Sell indirect
155
$25.08
$3.89K
James E Flynn
6 Jun 2022
10% owner
Sell indirect
171
$25.08
$4.29K
James E Flynn
6 Jun 2022
10% owner
Sell indirect
11,868
$25.29
$300.14K
James E Flynn
6 Jun 2022
10% owner
Sell indirect
13,132
$25.29
$332.11K
Edwin Jonathan Tucker
1 Oct 2021
Chief Medical Officer
Sell
1,364
$19.26
$26.26K
Peter Radovich
1 Oct 2021
Chief Operating Officer
Sell
1,364
$19.26
$26.26K
Lara Longpre
1 Oct 2021
Chief Development Officer
Sell
961
$19.26
$18.51K
Ian Clements
1 Oct 2021
Chief Financial Officer
Sell
1,574
$19.26
$30.31K
Pamela Vig
1 Oct 2021
Chief Scientific Officer
Sell
1,364
$19.26
$26.26K
Christopher Peetz
1 Oct 2021
President and CEO
Sell
3,672
$19.26
$70.71K
James E Flynn
9 Jul 2021
10% owner
Sell indirect
99,325
$15.81
$1.57M
James E Flynn
7 Jul 2021
10% owner
Sell indirect
6,837
$15.87
$108.50K
James E Flynn
6 Jul 2021
10% owner
Sell indirect
49,239
$16.20
$797.43K
James E Flynn
2 Jul 2021
10% owner
Sell indirect
10,599
$17.01
$180.30K
Show all 218 transactions →

What was left out

Form 4 filings counted 314
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 49
Sales at will 79
Transactions with no price 2
Shares from compensation/vesting 77,812,862
Sales filed before the plan box existed 19
History held since 18 Jul 2019